United Capital Financial Advisors’s Repligen RGEN Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q1
$327M Buy
2,773,980
+3,118
+0.1% +$436K 2.01% 7
2025
Q4
$454M Buy
2,770,862
+14,919
+0.5% +$2.34M 2.73% 5
2025
Q3
$368M Buy
+2,755,943
New +$335M 2.64% 5
2024
Q2
Sell
-1,307
Closed -$240K 1100
2024
Q1
$240K Sell
1,307
-191
-13% -$36.4K ﹤0.01% 956
2023
Q4
$269K Buy
1,498
+88
+6% +$13.7K ﹤0.01% 910
2023
Q3
$224K Sell
1,410
-12
-0.8% -$1.96K ﹤0.01% 781
2023
Q2
$201K Buy
+1,422
New +$228K ﹤0.01% 857

Other funds holding RGEN

United Capital Financial Advisors's RGEN Position: Q1 2026 in Review

United Capital Financial Advisors increased its Repligen (RGEN) stake by 0.11% in Q1 2026, buying an estimated $436K and bringing the position to 2,773,980 shares worth $327M. The position accounts for 2.01% of the portfolio, ranked #7.

United Capital Financial Advisors first reported a position in RGEN in Q2 2023 and has held it in 7 quarters since. The position peaked at $454M in Q4 2025. 441 funds tracked by Wall St. Rank hold RGEN as of Q1 2026.

  • United Capital Financial Advisors held 2,773,980 shares of Repligen worth $327M as of Q1 2026.
  • United Capital Financial Advisors bought 3,118 Repligen shares in Q1 2026, an estimated $436K.
  • Repligen made up 2.01% of United Capital Financial Advisors's portfolio in Q1 2026, its #7 holding.
  • United Capital Financial Advisors first reported a position in Repligen in Q2 2023 and has held it in 7 quarters since.
  • United Capital Financial Advisors's Repligen position peaked at $454M in Q4 2025.
  • 441 funds tracked by Wall St. Rank held Repligen as of Q1 2026.

Based on United Capital Financial Advisors's 13F filing for Q1 2026, filed 15 May 2026.